|
PHOSPHO2 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 3.4096000000039E-06 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
4.4138000000471E-06 |
| Normal-vs-Stage2 |
1.361300E-03 |
| Normal-vs-Stage3 |
4.190800E-04 |
| Normal-vs-Stage4 |
3.434900E-04 |
| Stage1-vs-Stage2 |
9.625200E-01 |
| Stage1-vs-Stage3 |
9.408800E-01 |
| Stage1-vs-Stage4 |
4.155400E-01 |
| Stage2-vs-Stage3 |
9.882400E-01 |
| Stage2-vs-Stage4 |
4.266800E-01 |
| Stage3-vs-Stage4 |
3.901600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.66810999999711E-05 |
| Normal-vs-AfricanAmerican |
7.568200E-04 |
| Normal-vs-Asian |
2.755500E-02 |
| Caucasian-vs-AfricanAmerican |
7.189600E-01 |
| Caucasian-vs-Asian |
9.025800E-01 |
| AfricanAmerican-vs-Asian |
8.222200E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.04090000455182E-08 |
| Normal-vs-Female |
4.000300E-02 |
| Male-vs-Female |
4.206300E-04 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
1.91454999999285E-05 |
| Normal-vs-Extreme_Weight |
1.37079999995571E-06 |
| Normal-vs-Obese |
7.84480000000087E-05 |
| Normal-vs-Extreme_Obese |
2.703000E-03 |
| Normal_Weight-vs-Extreme_Weight |
7.872600E-01 |
| Normal_Weight-vs-Obese |
5.796200E-01 |
| Normal_Weight-vs-Extreme_Obese |
9.238800E-01 |
| Extreme_Weight-vs-Obese |
3.603000E-01 |
| Extreme_Weight-vs-Extreme_Obese |
9.519000E-01 |
| Obese-vs-Extreme_Obese |
6.778000E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.746400E-01 |
| Normal-vs-Age(41-60Yrs) |
6.17429999999475E-05 |
| Normal-vs-Age(61-80Yrs) |
6.49690000020797E-07 |
| Normal-vs-Age(81-100Yrs) |
6.801500E-03 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.652100E-02 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.255600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
1.975050E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.186200E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
7.851000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
9.853600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
5.66860000050795E-07 |
| Normal-VS-Type2 PRCC |
1.000690E-04 |
| Normal-VS-KIRP CIMP |
2.314800E-01 |
| Normal-VS-Unclassified PRCC |
1.475290E-03 |
| Type1 PRCC-VS-Type2 PRCC |
5.012000E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.192600E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
5.131600E-01 |
| Type2 PRCC-VS-KIRP CIMP |
2.477800E-01 |
| Type2 PRCC-VS-Unclassified PRCC |
8.989800E-01 |
| KIRP CIMP-VS-Unclassified PRCC |
3.528000E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.94670000008834E-07 |
| Normal-vs-N1 |
1.018960E-01 |
| Normal-vs-N2 |
2.174000E-02 |
| N0-vs-N1 |
8.852100E-02 |
| N0-vs-N2 |
9.064800E-01 |
| N1-vs-N2 |
4.222400E-01 |
|
|
